Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose dabigatran PK/PD and safety study in children with venous thromboembolism
NL-OMON37049Phase 2Withdrawn
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dabigatran in venous thromboembolism (VTE), sponsored by Boehringer Ingelheim. Planned start Jul 2012; status: withdrawn.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NL-OMON37049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37049.